Pharmacogenomics Knowledge for Personalized Medicine

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical pharmacology and therapy

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/clpt.2012.96PMID 22992668PMCID PMC3660037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preventing and reporting adverse drug events: pharmacovigilance for the clinical nurse specialist.

  2012cited by this paper
• Implementing Personalized Medicine: Development of a Cost‐Effective Customized Pharmacogenetics Genotyping Array

  2012cited by this paper
• Optimizing Drug Outcomes Through Pharmacogenetics: A Case for Preemptive Genotyping

  2012cited by this paper
• The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics

  2012cited by this paper
• Clopidogrel: A Case for Indication‐Specific Pharmacogenetics

  2012cited by this paper
• Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease.

  2011cited by this paper
• HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

  2011cited by this paper
• CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

  2011cited by this paper
• Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

  2011cited by this paper
• From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.

  2011cited by this paper
• Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use

  2008cited by this paper
• Prasugrel versus clopidogrel in patients with acute coronary syndromes.

  2007cited by this paper
• Defining the opportunity for pharmacogenetic intervention in primary care.

  2006cited by this paper

• The quantitative impact of metabolism-inhibiting drugs on the occurrence of adverse drug reactions-A backward selection approach.

  2026cites this paper
• Docetaxel-Induced Toxicities in Patients With Breast Cancer With CYP3A4*22 Alleles

  2026cites this paper
• Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study.

  2026cites this paper
• An integrative neurogenomics workflow for precision medicine in neurodegenerative disorders.

  2026cites this paper
• A multi-ancestry genetic reference for the Quebec population

  2026influential citation
• Pharmacogenetic association study of cannabis use in chronic pain.

  2026cites this paper
• A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response Outcomes

  2026cites this paper
• Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort

  2026cites this paper
• Systematic Examination of Gene Expression and Proteomic Evidence Across Tissues Supports the Role of Mitochondrial Dysregulation in ME/CFS.

  2026cites this paper
• Pharmacogenomic Calling From Whole‐Exome Sequencing in the Taiwanese Population—A Real‐World Experience

  2026influential citation
• A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populations.

  2026cites this paper
• An open-source clinical bioinformatics pipeline for real-world NGS implementation: translating genomic variants into actionable treatment strategies in oncology

  2026cites this paper
• The Effect of Post-Transplant Cyclophosphamide Administration on Graft-Versus-Host Disease in Allogeneic Bone Marrow Transplantation

  2026cites this paper
• Pharmacogenomics knowledge, attitudes, and perceptions among pharmacists in the Asir Region, Saudi Arabia: a cross-sectional analysis

  2026cites this paper
• Investigating the genetic factors of medication dosing using biobank-linked drug purchase data

  2025cites this paper
• Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer

  2025cites this paper
• Polygenic and pharmacogenomic contributions to medication dosing: a real-world longitudinal biobank study

  2025cites this paper
• Lung cancer biomarkers.

  2025cites this paper
• ԴԵՂԵՐԻ ՖԱՐՄԱԿՈԳԵՆՈՄԻԿԱԿԱՆ ՀԵՏԱԶՈՏՈՒԹՅՈՒՆՆԵՐԻ ՆՇԱՆԱԿՈՒԹՅՈՒՆԸ ԱՆՀԱՏԱԿԱՆԱՑՎԱԾ ԴԵՂԱԲՈՒԺՄԱՆ ԳՈՐԾԸՆԹԱՑՈՒՄ

  2025cites this paper
• Predicting nifedipine responses in preterm labor: a risk score incorporating ABCG2 polymorphisms and clinical factors.

  2025cites this paper
• Identification of Therapeutic Targets for Osteoporosis through Multiomics Integration and the Potential Dual Role of Androgen Receptor Signaling in Its Pathophysiology

  2025cites this paper
• Direct-to-Consumer Genetic Testing.

  2025cites this paper
• Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) Regimen

  2025cites this paper
• Bioinformatics-based screening and prediction of compounds and antigen epitopes for immune targets with point mutations in colitis-associated colorectal cancer

  2025cites this paper
• Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders

  2025cites this paper
• Artificial intelligence coupled to pharmacometrics modelling to tailor malaria and tuberculosis treatment in Africa

  2025cites this paper
• Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling

  2025cites this paper
• Evaluation of pharmacogenomic information in drug labeling: a case study from Jordan.

  2025cites this paper
• The effect of ponicidin on CFA-induced chronic inflammatory pain and its mechanism based on network pharmacology and molecular docking

  2025cites this paper
• Current Progress in Patient-Specific Drug Formulations

  2025cites this paper
• A LARGE-SCALE PHARMACOGENOMIC KNOWLEDGE GRAPH FOR DRUG-GENE-VARIANT-DISEASE DISCOVERY

  2025cites this paper
• Efficacy of low-dose primaquine plus artemether-lumefantrine or dihydroartemisinin-piperaquine for radical cure of Plasmodium vivax in the Solomon Islands: a randomised clinical trial

  2025cites this paper
• Pharmacogenetic testing coverage by Canadian insurance providers.

  2025cites this paper
• Benchmarking large language models for replication of guideline-based PGx recommendations

  2025cites this paper
• CYP2D6 UM phenotype is not related to suicide attempts in depressive patients in secondary psychiatric care

  2025cites this paper
• Preventing adverse drug reactions and more: current clinical use of pharmacogenetic testing

  2025cites this paper
• Exploration of Pharmacological Mechanism of Kaempferol in Treating Rheumatoid Arthritis based on Network Pharmacology, Molecular Modelling, and Experimental Validation.

  2025cites this paper
• Computational Systems Biology Methods for Cross‐Disease Comparison of Omics Data

  2025cites this paper
• A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response Outcomes

  2025cites this paper
• A comprehensive assessment of pharmacogenomic annotation tools for next-generation sequencing data: an emphasis on cyp2d6 and vietnamese genomic data

  2025cites this paper
• Pharmacogenomics and chronotherapy of drug-induced cardioprotection in acute myocardial infarction

  2025cites this paper
• Impact of CYP450 and Transporter Polymorphisms on Dutasteride–Tamsulosin Exposure and Tolerability

  2025cites this paper
• The Consortium for Genomic Diversity, Ancestry, and Health in Colombia (CÓDIGO): building local capacity in genomics and bioinformatics

  2025cites this paper
• Pharmacogenomic Profiling of Frequently Prescribed Medications Among Geriatric Patients in a Tertiary Care Setting in Southwestern India

  2025cites this paper
• Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study

  2025cites this paper
• Exploration of the mechanism of Polyphyllin I against hepatocellular carcinoma based on network pharmacology, molecular docking and experimental validation

  2025cites this paper
• Design and Implementation of PharMe: A Mobile Application to Return Pharmacogenomic Test Results to Patients

  2025cites this paper
• The Consortium for Genomic Diversity, Ancestry, and Health in Colombia (CÓDIGO): building local capacity in genomics, bioinformatics, and precision medicine

  2025cites this paper
• Pharmacogenomic Testing for CYP2C19 Variants among Stroke Patients Treated with Clopidogrel: Opportunity for the Clinical Laboratory?

  2025cites this paper
• Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on UGT1A1 Genotypes: A Systematic Review

  2025cites this paper
• A multi-ancestry genetic reference for the Quebec population

  2025cites this paper
• Genetic landscape and therapeutic evolution of cyclophosphamide: spotlight on breast cancer.

  2025cites this paper
• Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine

  2025cites this paper
• Unraveling the Gut Microbiota-mediated Anti-tumor Mechanisms of ShenXia KuanZhong Decoction in Gastric Cancer: a Systems Biology and Dose-weighted Network Pharmacology Approach

  2025cites this paper
• Pharmacogenetic Information on Drug Labels of the Italian Agency of Medicines (AIFA): Actionability and Comparison Across Other Regulatory Agencies

  2025cites this paper
• Review on application and development of pharmacogenomics of adverse drug reactions

  2025cites this paper
• High-coverage whole-genome sequencing of a Jakun individual from the “Orang Asli” Proto-Malay subtribe from Peninsular Malaysia

  2025cites this paper
• Microbial Crosstalk with Therapy: Pharmacomicrobiomics in AML—One Step Closer to Personalized Medicine

  2025cites this paper
• Rapid and cost-effective screening of therapeutic targets for isoquercitrin in insulin resistance using virtual methods and fiber SPR biosensing

  2025cites this paper
• 23andYOU: How Pharmacogenomics Is Important to You and Your Patients.

  2025cites this paper
• Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients

  2025cites this paper
• A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors

  2025cites this paper
• Comparative analysis on artificial intelligence methods for DTI and DTBA prediction in drug repurposing

  2025cites this paper
• ESR1 Variants and Subcontinental Genomic Ancestry: Insights from the 1000 Genomes Project and Native American Populations

  2025cites this paper
• Inferring Drug–Gene Relationships in Cancer Using Literature-Augmented Large Language Models

  2025cites this paper
• Kansui-liquorice enhances the “water-expelling” effect of Gansui Banxia decoction in rats with malignant ascites by targeting the NPs/NPRs/cGMP/PKGⅡ pathway and T cell immunity

  2025cites this paper
• Quantum Computing's Future Role in AI-Driven Drug Discovery

  2025cites this paper
• Study on the Mechanism of Dihydromyricetin in Alleviating Depressive-Like Behavior in Rats Based on Network Pharmacology

  2025cites this paper
• Moving Away from One-Size-Fits-All: Assessing the Use of Pharmacogenetic-Guided Medication Therapy in Pediatric Patients with Chronic Pain

  2025influential citation
• Human xenobiotic metabolism proteins have full-length and split homologs in the gut microbiome

  2025cites this paper
• Genetic polymorphisms and adverse reactions to antituberculosis therapy

  2025cites this paper
• Mechanism of Fangji Huangqi decoction against acute kidney injury based on network pharmacology and experimental validation.

  2024cites this paper
• Pharmacogenomic landscape of the Thai population from genome sequencing of 949 individuals

  2024influential citation
• Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population

  2024cites this paper
• Comparison of targeted next generation sequencing assays in non-small cell lung cancer patients

  2024cites this paper
• Tramadol-related fatalities: Metabolic ratios & SNPs/INDELs belonging to UGT1A8, UGT2B7, ABCC2, and SLC22A1.

  2024cites this paper
• Genome-wide Mendelian randomization identifies drugs associated with body height

  2024cites this paper
• Methadone metabolism and cytochrome P450 polymorphisms: a systematic review and meta-analysis

  2024cites this paper
• Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine

  2024cites this paper
• Application of machine learning in drug side effect prediction: databases, methods, and challenges

  2024cites this paper
• Widespread Impact of Natural Genetic Variations in CRISPR-Cas9 Outcomes

  2024cites this paper
• Knowledge and attitudes towards genomic medicine and pharmacogenomics of medical undergraduate students in Sri Lanka: a cross-sectional study

  2024cites this paper
• Improving the efficacy of combinatorial pharmacogenetic testing in schizophrenia therapy in China: a meta-analysis

  2024cites this paper
• Tangeretin exerts and modulates the anxiolytic effects of the GABAkine drugs diazepam and flumazenil in mice: Molecular interventions through animal behavior and molecular dynamic simulations

  2024cites this paper
• SPathDB: a comprehensive database of spatial pathway activity atlas

  2024cites this paper
• Boosting GPT models for genomics analysis: generating trusted genetic variant annotations and interpretations through RAG and Fine-tuning

  2024influential citation
• Improving Collaborative Interactions Between Humans and Artificial Intelligence to Achieve Optimal Patient Outcomes in the Healthcare Industry

  2024cites this paper
• Investigating the potential hub genes and mechanisms of Artemisia annua L. against breast cancer based on network pharmacology and molecular docking

  2024cites this paper
• Toward a Unified Graph-Based Representation of Medical Data for Precision Oncology Medicine

  2024cites this paper
• AI coupled to pharmacometric modelling to tailor malaria and tuberculosis treatment in Africa

  2024cites this paper
• The role of CYP2C19*2 variant and other factors in clopidogrel resistance in Montenegrin ACS patients

  2024cites this paper
• Integrando farmacologia de rede e docagem molecular para avaliar o potencial terapêutico da tangeritina contra o meduloblastoma

  2024cites this paper
• Deciphering single-cell gene expression variability and its role in drug response

  2024cites this paper
• Prevalence of actionable pharmacogenetic variants and high‐risk drug prescriptions: A Swiss hospital‐based cohort study

  2024cites this paper
• Reveal the potent antidepressant effects of Zhi-Zi-Hou-Pu Decoction based on integrated network pharmacology and DDI analysis by deep learning

  2024cites this paper
• Revolutionized attitude toward recurrent pregnancy loss and recurrent implantation failure based on precision regenerative medicine

  2024cites this paper
• CYP3A4*1B but Not CYP3A5*3 as Determinant of Long-Term Tacrolimus Dose Requirements in Spanish Solid Organ Transplant Patients

  2024cites this paper
• An Evidence-Based Systematic Review: The Impact of Artificial Intelligence in Pharmacology and Health Research

  2024cites this paper
• Human xenobiotic metabolism proteins have full-length and split homologs in the gut microbiome

  2024cites this paper
• A Method for Predicting Allelic Variants of Single Nucleotide Polymorphisms.

  2024cites this paper